Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Mycophenolate Mofetil Hydrochloride Patent Expiration

Mycophenolate Mofetil Hydrochloride was first introduced by Roche Palo Alto Llc in its drug Cellcept on Aug 12, 1998. 9 different companies have introduced drugs containing Mycophenolate Mofetil Hydrochloride.


Mycophenolate Mofetil Hydrochloride Patents

Given below is the list of patents protecting Mycophenolate Mofetil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cellcept US5543408 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof Sep 15, 2013

(Expired)

 Roche Palo



Mycophenolate Mofetil Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Mycophenolate Mofetil Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Mycophenolate Mofetil Hydrochloride. The first generic version for Mycophenolate Mofetil Hydrochloride was by Ph Health Ltd and was approved on Oct 28, 2016. And the latest generic version is by Bpi Labs Llc and was approved on Jun 1, 2023.

Given below is the list of companies who have filed for Mycophenolate Mofetil Hydrochloride generic, along with the locations of their manufacturing plants worldwide.